Hsing-Mao Chu
Chief Executive Officer T-E Meds
Seminars
Monday 12th October 2026
Enabling Versatile Mono & Dual Payload ADCs Through Diverse Bundles, Including Azido & Drug Bundles
10:30 am
- Enabling flexible 2- or 4-site conjugation per antibody to allow precise control of payload ratios and combinations to develop mono or dual payload ADCs
- Explaining how one integrated Drug Bundle conjugation process supports diverse ADC modalities through cysteine/thiol–maleimide conjugation and glycan-specific or MTGase-enabled click conjugation
- Exploring how Drug Bundle-based ADCs have the potential to enhance stability and efficacy while helping overcome drug resistance
